Skip to content
Boca Raton City Online – Lifestyle
Author:
Apollomics Inc.
Apollomics Receives Nasdaq Deficiency Notice Regarding Minimum Market Value Requirement and Updates Rights for Vebreltinib (APL-101) in Asia
June 24, 2026
Apollomics Reports Full Year 2025 Financial Results and Provides Clinical Updates and Business Progress
April 27, 2026
Apollomics Inc. Announces $2.0 Million Bridge Financing
April 1, 2026